Latest Breaking News On - Robert blumlytham partners - Page 1 : comparemela.com

Acasti Pharma (ACST) Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102

Acasti Pharma (ACST) Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJan dalviseExchange commissionAcasti pharma incCompany nasdaqRobert blumlytham partnersSecurities exchangeRegulation services providerAtaxia telangiectasiaChief executive officerOrphan drug designationSubarachnoid hemorrhagePostherpetic neuralgiaSecurities litigation reform actSecurities actSecurities exchange act

Acasti Pharma (ACST) Announces Preliminary Topline Results Met All Primary Outcome Measures in Study for GTX-101

Acasti Pharma (ACST) Announces Preliminary Topline Results Met All Primary Outcome Measures in Study for GTX-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJan dalviseExchange commissionAcasti pharma incCompany nasdaqRobert blumlytham partnersSecurities exchangeRegulation services providerWall streetPostherpetic neuralgiaChief executive officerAtaxia telangiectasiaOutcome definitionsPreliminary topline findings areSingle doseOrphan drug designation

Acasti Pharma Announces Annual Grants of Performance Stock Options

Acasti Pharma Announces Annual Grants of Performance Stock Options
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesExchange commissionAcasti pharma incCompany nasdaqRobert blumlytham partnersSecurities exchangeRegulation services providerStock option planOrphan drug designationSubarachnoid hemorrhagePostherpetic neuralgiaSecurities litigation reform actSecurities actSecurities exchange actD alvisechief executive officertelAcasti pharma